• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Gene Modification of Oxygen Responsiveness by Erythropoietin Gene

Research Project

Project/Area Number 13671046
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionUniversity of Tsukuba

Principal Investigator

IMAGAWA Shigehiko  University of Tsukuba, Division of Hematology Institute of Clinical Medicine, Assistant Professor, 臨床医学系, 講師 (60231164)

Co-Investigator(Kenkyū-buntansha) YAMAMOTO Masayuki  University of Tsukuba, TARA Center, Professor, 基礎医学系, 教授 (50166823)
Project Period (FY) 2001 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥4,100,000 (Direct Cost: ¥4,100,000)
Fiscal Year 2003: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 2002: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 2001: ¥2,500,000 (Direct Cost: ¥2,500,000)
KeywordsErythropoietin / Gene expression / GATA / HIF-1 / L-NMMA / L-arginine / Cadmium / GATA inhibitor / Gene expression / Hydrogen peroxide
Research Abstract

Erythropoietin (Epo) gene expression is negatively regulated by GATA, which binds to the GATA site in the Epo promoted and also positively regulated by hypoxia inducible factor-1(HIF 1), which binds to the hypoxia responsive element (HRE) in the Epo enhancer. We have the following results along with this evidence
1) N^G-monomethyl L-arginine (L-NMMA) has been increased in the patients with chronic renal failure. The addition of L-NMMA(NOS inhibitor) into the Hep3B cells, inhibits NO・cGMP production, increases GATA binding activity and mRNA expression, ad inhibits Epo promoter activity and induces the anemia with renal disease (Blood 96 : 1716-1722, 2000). However, pre-treatment with L-arginine reversed the anemia with renal disease in vitro Hep3B cells and in an in vivo mouse assay (Kidney Int 61 : 39604, 2002)
2) The addition of H_2O_2 inhibits Epo gene expression by increasing GATA binding activity and inducing degradation of HIF-1α(J Cell Physiol 186 : 260-267, 2001)
3) The addition of … More cadmium inhibits Epo gene expression by inhibiting the binding activity of HIF-1, not by GATA (Arch. Toxicol 77 : 267-273, 2003)
4) Mouse Epo gene expression is also negatively regulated by GATA, which bonds to the GATA site in the mouse Epo promoter like human Epo gene (Int J Hematol 74 : 376 381, 2002)
5) To better understand how human adapt to hypoxia, the levels of Hb, serum Epo and VEGF were measured in 106 patients with severe obstructive sleep apnea-hypopnea syndrome. The results indicated that temporal hypoxic stimulation increases Hb. Furthermore, a minor increase in Epo and a substantial increase in VEGF were found (Blood 98:1255-1257, 2001)
6) K-7174 (a GATA-specific inhibitor) improved Epo production that had been inhibited by IL-1β and TNF-α, which have been increased in the patients with anemia of chronic disease or L-treatment in Hep3B cells in vitro, and in an in vivo mouse assay (FASEB J 17 : 1742-1744, 2003)
Recently, we have analyzed Epo gene expression system by transgenic mice with BAC to identify the kidney inducible element (KIE). Peritubular capillary interstitial cells are the major Epo productive cells. KIE is located between 22〜8Kbp upstream from CAP site (In preparation) Less

Report

(4 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • 2001 Annual Research Report
  • Research Products

    (41 results)

All Other

All Publications (41 results)

  • [Publications] Imagawa S, et al.: "Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome."Blood. 98. 1255-1257 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S, et al.: "Elevation of vascular endothelial growth factor in patients with obstructive sleep apnea-hypopnea syndrome is not due to increased platelet counts."Blood. 99. 393-394 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Suzuki N, et al.: "Erythroid-specific expression of erythropoietin receptor rescued its null mutant mice from lethality."Blood. 100. 2279-2288 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Obara N, et al.: "Suppression of erythropoietin gene expression by cadmium depends on inhibition of HIF-1 not stimulation of DATA-2"Arch Toxicol. 77. 267-273 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S, et al.: "A GATA-specific inhibitor (K-7174) rescues anemia induced by IL-1β, TNF-α or L-NMMA."FASEB J. 17. 1742-1744 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Suzuki N, et al.: "Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels."Blood. 15. 3575-3583 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S: "Function of transcription factor GATA-2. Molecular Biology and Clinical Use of Erythropoietin. (W.Jelkmann Eds)"F.P.GRAHAM PUBLISHING CO.. 129-144 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tabata M, Tanrumoto T, Ohmine K, Furukawa Y, Hatake K, Yamamoto Ni, Imagawa S.: "Stimulation of GATA 2 as a mechanism of hydrogen peroxide suppression in hypoxia-induced erythropoietin gene expression"J Cell Physiol. 186. 260-267 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S, Yamagudu Y Higuchi M, Neidu T, Hasegawa Y, Mukai H.Y, Suzuld N, Yamamoto M, NagasawaT.: "levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome"Blood. 98. 1255-1257 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ohmine K, Ota J, Ueda M, Ueno S, Yoshida K, Yamashita Y, Kirito K, Imagawa S, Nakamura Y, Saito K, Akutsu M, Muani K, Kano Y, Komatsu N, Ozawa K, Mano H.: "Characterzation of stage progression in chronic myeloid leukemia by DNA microarray analysis with purr hematopoietic stem cells"Oncogene. 20. 8249-8257 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S, Tarurnoto T, Suzuki N, Mukai H.Y, Hasegawa Y, Higuchi M, Neichi T, Ozawa K, Yamamoto M, Nagasawa T.: "L-arginine Rescues Decreased Erythropoietin Gene Expression by Stimulating GATA-2 with L-NMMA"Kidney Int. 61. 396-404 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S, Yarrzagudu Y, Higuchi M, Neidu T, Hasegawa Y, Mukai H.Y, Suzuki N, Yamarnoto M, NagasawaT.: "Elevation of vascular endothelial growth factor in patients with obstructive sleep apnea-Hypopnea syndrome is not due to increased platelet counts"Blood. 99. 393-394 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S, Suzuki N, Ohmine K, Obara N, Mukai H.Y, Ozawa K, Yamamoto M, NagasawaT.: "GATA-2 suppresses erythropoietin gene expression through GATA site in mouse erythroPoietin gene promoter"Int J Hematol. 74. 376-381 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Suzuki N, Ohneda O, Takahaslu S, Higuchi M, Mukai H, Imagawa S, Yamamoto M.: "Frythroid-specific expression of erythropoietin receptor rescued its null mutant mice from lethality"Blood. 100. 2279-2288 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Obara N, Imagawa S, Nakano Y, Suzuki N, Yamamoto M, Nagasawa T.: "Suppression of erythropoietin gee expression by cadmium depend on inhibition of HIF-1, not stimulation of GATA-2"Arch Toxicol. 77. 267-273 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S., Nakano Y, Obara N, Suzuki N, Doi T, Kodama T, Nagasawa T, Yamamoto M.: "AGATA-specific inhibitor (K-7174) rescues anemia induced by IL-1β, TNF-α or L-NMMA"FASEBJ. 17. 1742-1744 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Suzuki N, Suwabe N, Ohneda O, Obara N, Imagawa S, Pan X, Motohashi H, Yamamoto M.: "Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels"Blood. 15. 3575-3583 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Obara N, Imagawa S, Nakano Y, Yamamoto M, Noguchi T, Nagasawa T.: "Hematological Aspects of a Novel 9-Aminoanthracycline, Amrubicin"Cancer Science. 94. 1104-1106 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S, Yamaguchi Y, Ogawa K, Obara N, Suzuki N, Yamamoto Y, Nagasawa T.: "Interleukin-6 and tumor necrosis factor α in patients with obstructive sleep apnea-hypopnea syndrome"Respiration. 71. 24-29 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S.: "Function of transcription factor GATA-2. Erythropoietin : Molecular Biology and Clinical Use (W.Jelkmann Eds)"F.P.GRAHAM PUBLISHING CO., Johnson City, TN. 129-144 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Imagawa S, et al.: "Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome"Blood. 98. 1255-1257 (2001)

    • Related Report
      2003 Annual Research Report
  • [Publications] Imagawa S, et al.: "Elevation of vascular endothelial growth factor in patients with obstructive sleep apnea-hypopnea syndrome is not due to increased platelet counts"Blood. 99. 393-394 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Suzuki N, et al.: "Erythroid-specific expression of erythropoietin receptor rescued its null mutant mice from lethality"Blood. 100. 2279-2288 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Obara N, et al.: "Suppression of erythropoietin gene expression by cadmium depends on inhibition of HIF-1 not stimulation of GATA-2"Arch Toxicol. 77. 267-273 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Imagawa S, et al.: "A GATA-specific inhibitor (K-7174) rescues anemia induced by IL-1β, TNF-α or L-NMMA"FASEB J. 17. 1742-1744 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Suzuki N, et al.: "Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels"Blood. 15. 3575-3583 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Imagawa S: "Function of transcription factor GATA-2. Molecular Biology and Clinical Use of Erythropoietin"F.P.GRAHAM PUBLISHING CO., (W.Jelkmann Eds). 129-144 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Tabata M, et al.: "Stimulation of GATA-2 as a mechanism of hydrogen peroxide suppression in hypoxia-induced erythropoietin gene expression"Journal of Cellular Physiology. 186. 260-267 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Imagawa S, et al.: "Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome"Blood. 98. 1255-1257 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Imagawa S, et al.: "L-arginine rescues decreased erythropoietin gene expression by stimulating GATA-2 with L-NMMA"Kidney International. 61. 396-404 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Imagawa S, et al.: "Elevation of vascular endothelial growth factor in patients with obstructive sleep apnea-hypopnea syndrome is not due to increased platelet counts"Blood. 99. 393-394 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Imagawa S, et al.: "GATA-2 suppresses erythropoietin gene expression through GATA site in mouse erythropoietin gene promoter"International Journal of Hematology. 74. 376-381 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Suzuki N, et al.: "Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality"Blood. 100. 2279-2288 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Imagawa S: "Function of transcription factor GATA-2. Molecular Biology and Clinical Use of Erythropoietin"F.P. GRAHAM PUBLISHING CO., (W.Jelkmann Eds). 129-144 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Tabata M. et al.: "Stimulation of GATA-2 as a mechanism of hydrogen peroxide suppression in hypoxia-induced erythropoietin gene expression"Journal of Cellular Physiology. 186. 260-267 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Imagawa S. et al.: "Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea hypopnes syndrome"Blood. 98. 1255-1257 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ohmine K. et al.: "Characterization of stage progression in chronic myeloid leukemia by DNA microarray analysis with purified hematopoietic stem cells"Oncogene. 20. 8249-8257 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Imagawa S. et al.: "L-arginine rescues decreased erythropoietin gene expression by stimulating GATA-2 with N^G-monomethy1 L-arginine in Hep3B cells and N^G-nitro-L-arginine methy1 ester in BDF1 mice"Kidney International. 61. 396-404 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Imagawa S. et al.: "Elevation of vascular endothelial growth factor in patients with obstructive sleep apnea-hypopnea syndrome is not due to increased platelet counts"Blood. 99. 393-394 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Imagawa S. et al.: "GATA-2 suppresses erythropoietin gene expression through GATA site in mouse erythropoietin gene promoter"International Journal of Hematology. (in press).

    • Related Report
      2001 Annual Research Report
  • [Publications] Imagawa S.: "Function of transcription factor GATA-2. Moleculay Biology and Clinical Use of Erythropoietin"F.P.GRAHAM PUBLISHING CO (W.Jelkmann Eds) (in press).

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi